Literature DB >> 3112316

Lupus anticoagulant and cerebral infarction: therapeutic implications.

V L Babikian, J D Levine.   

Abstract

The clinical hematological and radiological findings in a patient with stroke and the lupus anticoagulant are presented, and therapeutic alternatives are reviewed. The importance of recognizing this association is stressed because of its potential therapeutic implications.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3112316     DOI： 10.1007/bf00314297

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  11 in total

1.  Association of lupuslike anticoagulant and nonvasculitic cerebral infarction.

Authors:  N F Tabachnik-Schor; S A Lipton
Journal:  Arch Neurol       Date:  1986-08

2.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

3.  Cerebral infarction associated with lupus anticoagulants--preliminary report.

Authors:  R G Hart; V T Miller; B M Coull; V Bril
Journal:  Stroke       Date:  1984 Jan-Feb       Impact factor: 7.914

4.  Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant.

Authors:  M L Boey; C B Colaco; A E Gharavi; K B Elkon; S Loizou; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-08

5.  Recurrent ischemic attacks in two young adults with lupus anticoagulant.

Authors:  G Landi; M V Calloni; M Grazia Sabbadini; P Mannuccio Mannucci; L Candelise
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

6.  [Chorea and systemic lupus erythematosus with circulating anticoagulant. 3 cases].

Authors:  B Bouchez; G Arnott; P Y Hatron; A Wattel; B Devulder
Journal:  Rev Neurol (Paris)       Date:  1985       Impact factor: 2.607

7.  Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis.

Authors:  J G D'Alton; D N Preston; J Bormanis; M S Green; G R Kraag
Journal:  Stroke       Date:  1985 May-Jun       Impact factor: 7.914

8.  Studies on a circulating anticoagulant in procainamide-induced lupus erythematosus.

Authors:  R L Edwards; M E Rick; C J Wakem
Journal:  Arch Intern Med       Date:  1981-11

9.  Thrombosis in patients with the lupus anticoagulant.

Authors:  J R Mueh; K D Herbst; S I Rapaport
Journal:  Ann Intern Med       Date:  1980-02       Impact factor: 25.391

10.  Fetal survival after prednisone suppression of maternal lupus-anticoagulant.

Authors:  W F Lubbe; W S Butler; S J Palmer; G C Liggins
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.